期刊文献+

肺炎克雷伯菌的分布与药敏性分析 被引量:12

Analysis of drug resistance and prevalence of Klebsiella pneumoniae strains isolated from hospitalized patients
原文传递
导出
摘要 目的统计2009-2010年肺炎克雷伯菌的分布、药敏性及流行状况,指导临床用药,控制医院感染。方法对2010年分离出肺炎克雷伯菌的162例住院患者进行标本、科室分布的统计及药敏分析;对其中多药耐药肺炎克雷伯菌作ESBLs、AmpC酶、碳青霉烯酶、新德里金属β-内酰胺酶(NDM)-1等试验。结果 162株肺炎克雷伯菌主要来自痰液,占76.54%,其次为尿液及伤口分泌物,分别占8.64%、6.79%;主要分布于ICU、呼吸内科,分别占51.23%、22.84%;产ESBLs肺炎克雷伯菌检出84株,检出率为51.85%,产AmpC酶检出20株,检出率为12.35%,产KPC酶检出17株,检出率为10.49%,没有检测到产新德里金属β-内酰胺酶(NDM)-1菌株。结论肺炎克雷伯菌耐药率比较高并且耐药因子多样,对多药耐药肺炎克雷伯菌有必要进行耐药机制的检测,以便控制医院感染。 OBJECTIVE To analyze distribution,drug susceptibility and prevalence of Klebsiella pneumoniae during 2009-2010,so as to guide the clinical application of medicine and control nosocomial infection.METHODS A total of 162 strains of K.pneumoniae isolated from inpatients in 2010 were collected,the specimen department distribution and drug sensitivity were analyzed;ESBLs,AMPC enzyme,carbapenemase and NDM-1 enzymes tests were carried out with multidrug-resistant K.pneumoniae strains.RESULTS Majority of the 162 strains of K.pneumoniae were isolated from sputum,accounting for 76.54%,followed by urine and wound secretions,accounting for 8.64% and 6.79% respectively.The strains were mainly distributed in ICU and respiratory medicine department,accounting for 51.23% and 22.84%,respectively.84 strains producing ESBLs enzyme were detected,with detection rate of 51.85%.20 strains of K.pneumoniae producing AMPC enzyme were detected,with detection rate of 12.35%.17 strains producing KPC enzyme were detected,with detection rate of 10.49%.There was no strain producing NDM-1 enzyme.CONCLUSION The resistance rate of K.pneumoniae is relatively high and there are various resistance factors.It is necessary to test drug-resistant mechanism of multidrug-resistant K.pneumoniaen which will benefit to the prevention and control of nosocomial infection.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2012年第8期1700-1702,共3页 Chinese Journal of Nosocomiology
关键词 多药耐药肺炎克雷伯菌 药敏试验 感染 Multidrug-resistant Klebsiella pneumoniae Drug susceptibility testing Infection
  • 相关文献

参考文献3

  • 1Deshpande LM,Jones RN,Fritsche TR. Occurrence and characterization of carbapenemaseproducing Enterobacteriacene Program(2000-2004)[J].Microbial Drug Resistance-Mechanisms Epidemiology and Disease,2006,(04):223-230. 被引量:1
  • 2Wei ZQ,Du XX,Yu YS. Plasm id-mediated KPC-2 in a Klebsiella pneumoniae isolte from China[J].Antimicrobial Agents and Chemotherapy,2007,(02):763-765. 被引量:1
  • 3Anderson KF,Lonsway DR,Rasheed JK. Evaluation of Methods to identify the Klebsiella pneumoniae carbapenemase in Enterobacteriaceae[J].Journal of Clinical Microbiology,2007,(08):2723-2272. 被引量:1

同被引文献67

  • 1张秋桂.产ESBLs大肠埃希菌和肺炎克雷伯菌耐药分析[J].中华医院感染学杂志,2007,17(4):457-458. 被引量:62
  • 2王玉红,邓敏,曾吉.肺炎克雷伯菌耐药机制研究进展[J].中华医院感染学杂志,2007,17(4):478-480. 被引量:43
  • 3Kumarasamy KK,Toleman MA,Walsh TR,et al. Emergence of anew antibiotic resistance mechanism in India, Pakistan, and theUK: a molecular, biological, and epidemiological study [J].Lancet Infect Dis, 2010, 10(9) : 597-602. 被引量:1
  • 4Yong D, Toleman MA, Giske CG, et al. Characterization of a NewMetallo-p-lactamase Gene, blaNDM-1, and a Novel ErythromycinEsterase Gene Carried on a Unique Genetic Structure in Klebsiellapneumoniae sequence Type 14 from India [J]. Antimicrob AgentsChemother, 2009, 53(12) : 5046-5054. 被引量:1
  • 5Fanos V,Verlato G,Dal Moro A, et al. Staphylococensepidermidis isolation and antibiotic resistance in a neonatalintensive care unit [J]. J Chenother,1995,7(1): 26-29. 被引量:1
  • 6Chong Y, Yakushiji H, Ito Y, et al. Clinical and molecularepidemiology of extended-spectrum P -lactamase-producingEscherichia coli and Klebsiella pneumoniae in a long-termstudy from Japan[J] . Eur J Clin Microbiol Infect Dis, 2011,30(1): 83-87. 被引量:1
  • 7Hansen DS, Schumacher H, Hansen F, et al. Extended-sp-ectrum p -lactamase (ESBL) in Danish clinical isolates ofEscherichia coli and Klebsiella pneumoniae: Prevalence, p -lactamase distribution, phylogroups, and co-resistance[J] .Scand J Infect Dis, 2012,44(3): 174-181. 被引量:1
  • 8Kang Cl, Chung DR, Ko KS, et al. Risk factors for infectionand treatment outcome of extended-spectrum P -lactamase-producing Escherichia coli and Klebsiella pneumonia bacte-remia in patients with hematologic malignancy [J] . AnnHematol, 2012, 91 (1): 115-121. 被引量:1
  • 9Clinical and Laboratory Standards Institute.Mbo-s20-2010 Performance standards for antimicrobial susceptibility testing(Twentieth Informational Supplement)[S] .Wayne:Clinical and Laboratory Standards Institute,2010:M100-S20. 被引量:1
  • 10National Nosocomial Infections Surveillance System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004[J]. Am J Infect Control. 2004, 32 (8) : 470-485. 被引量:1

引证文献12

二级引证文献72

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部